Biomarkers of basic activities of daily living in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 31, Issue 2, 2012, Pages 429-437

  Hall, James R ^a,b   Johnson, Leigh A ^c   Barber, Robert C ^b,c   Vo, Hoa T ^a   Scott Winter, A ^a   O'Bryant, Sid E ^b,c  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c University of North Texas Health Science Center   (United States)

Author keywords

Alzheimer's disease; basic activities of daily living; biomarkers; gender

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; EOTAXIN; FAS LIGAND; FERRITIN; FIBRINOGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LYMPHOTOXIN; STEM CELL FACTOR; STROMELYSIN; TENASCIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; VON WILLEBRAND FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF CARE; SEX DIFFERENCE;

EID: 84865597812     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111481     Document Type: Article

References (40)

1. Pereira FS, Yassuda MS, Oliveira AM, Forlenza OV (2008) Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr 20, 1104-1115.
2. Beck CK, Frank LB (1997) Assessing functioning and selfcare abilities in Alzheimer disease research. Alzheimer Dis Assoc Disord 11, 73-80. (Pubitemid 28029825)
3. Gallagher D, Ni Mhaolain A, Crosby L, Ryan D, Lacey L, Coen RF, Walsh C, Coakley D, Walsh JB, Cunningham C, Lawlor BA (2011) Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment. Am J Alzheimers Dis Other Demen 26, 110-114.
4. Wattmo C, Wallin AK, Londos E, Minthon L (2011) Risk factors for nursing home placement in Alzheimer's disease: A longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. Gerontologist 51, 17-27.
5. Knopman DS, Boeve BF, PetersenRC(2003) Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 78, 1290-1308. (Pubitemid 37193520)
6. Ashford JW, Kumar V, Barringer M, Becker M, Bice J, Ryan N,Vicari S (1992) Assessing Alzheimer severity with a global clinical scale. Int Psychogeriatrics 4, 55-74.
7. Reiman EM, McKhann GM, Albert MS, Sperling RA, Petersen RC, Blacker D (2011) Alzheimer's disease: Implications of the updated diagnostic and research criteria. J Clin Psychiatry 72, 1190-1196.
8. Marshall G, Fairbanks L, Tekin S, Vinters H, Cummings JL (2006) Neuropathologic correlates of activities of daily living in Alzheimer's disease. Alzheimer Dis Assoc Disord 20, 56-59. (Pubitemid 44356895)
9. Okonkwo OC, Alosco ML, Griffith HR, Mielke MM, Shaw LM, Trojanowski JQ, Tremont G, Alzheimer's Disease Neuroimaging Initiative (2010) Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: Normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol 67, 688-696.
10. Locascio JJ, Fukumoto H, Yap L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC (2008) Plasma amyloid betaprotein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol 65, 776-785. (Pubitemid 351831455)
11. Zuliani G, Guerra G, Ranzini M, Rossi L, Munari MR, Zurlo A, Bl̀e A, Volpato S, Atti AR, Fellin R (2007) High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. Int J Geriatr Psychiatry 22, 305-311. (Pubitemid 46680841)
12. Hall JR, Vo HT, Johnson LA, Barber RC, O'Bryant SE (2011) The link between cognitive measures and ADLs and IADL functioning in mild Alzheimer's: What has gender got to do with it? Int J Alzheimers Dis 2011, Article ID 276734.
13. Hall JR, Vo H, Johnson L, Barber R, Winter S, O'Bryant S (2012) Biomarkers and depressive symptoms in older women with and without cognitive impairment. J Behav Brain Sci 2(2).
14. Hall JR, Vo H, Johnson L, Barber R, Winter S, O'Bryant S (2011) Biomarkers and depressive symptoms in cognitively intact and Alzheimer's disease elderly males. Neurosci Med 2, 306-312.
15. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W, Polonikov A, Peters A, Theis FJ, Meitinger T, Kronenberg F, Weidinger S, Wichmann HE, Suhre K,Wang-Sattler R, Adamski J, Illig T (2011) Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 7, e1002215.
16. Waring S, O'Bryant SE, Reisch JS, Diaz-Arrastia R, Knebl J, Doody R for the Texas Alzheimer's Research Consortium (2008) The Texas Alzheimer's research consortium longitudinal research cohort: Study design and baseline characteristics. Texas Public Health J 60, 9-13.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 934-944.
18. Lawton MP, Brody EM (1969) Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
19. O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, Diaz-Arrastia R, Texas Alzheimer's Research Consortium (2010) A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 67, 1077-1081.
20. O'Bryant SE, Xiao G, Barber R, Reisch J, Hall J, Cullum CM, Doody R, Fairchild T, Adams P,Wilhelmsen K, Diaz-Arrastia R, Texas Alzheimer's Research and Care Consortium (2011) A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord 32, 55-62.
21. Zellner M, Veitinger M, Umlauf E (2009) The role of proteomics in dementia and Alzheimer's disease. Acta Neuropathol 118, 181-195.
22. Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, Juvancic-Heltzel J, Murray L (2008) Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. Geriatr Psychiatry Neurol 21, 166-170.
23. Selle H, Lamerz J, Buerger K, Dessauer A, Hager K, Hampel H, Karl J, Kellmann M, Lannfelt L, Louhija J, Riepe M, Rollinger W, Tumani H, Schrader M, Zucht HD (2005) Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Throughput Screen 8, 801-806. (Pubitemid 41771581)
24. Quinn TJ, Gallacher J, Deary IJ, Lowe GD, Fenton C, Stott DJ (2011) Association between circulating haemostatic measures and dementia or cognitive impairment-systematic review and meta-analyses. J Thromb Haemost 9, 1475-1482.
25. Swardfager W, Lanct̂ot K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry 68, 930-941.
26. Kim SM, Song J, Kim S, Han C, Park MH,KohY, Jo SA, Kim YY (2011) Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol 11, 51.
27. Schmitz T, Chew LJ (2008) Cytokines and myelination in the central nervous system. ScientificWorldJournal 8, 1119-1147.
28. Ǵomez-Nicola D, Valle-Argos B, Pallas-Bazarra N, Nieto-SampedroM(2011) Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Mol Biol Cell 22, 1960-1970.
29. Reitz C, van Rooij FJ, de Maat MP, den Heijer T, Hofman A, Witteman JC, Breteler MM (2008) Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study. Neurobiol Aging 29, 874-881. (Pubitemid 351601899)
30. Buchhave P, Zetterberg H, Blennow K, Minthon L, Janciauskiene S, Hansson O (2008) Soluble TNF receptors are associated with A-metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol Aging 31, 1877-1884.
31. Cheng X, Yang L, He P, Li R, Shen Y (2010) Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. J Alzheimers Dis 19, 621-630.
32. Rauch U (2004) Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci 61, 2031-2045. (Pubitemid 39149893)
33. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J (2011) Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol 178, 1509-1516.
34. Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ (2010) Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol 120, 385-399.
35. Simonsen AH, McGuire J, Podust VN, Hagnelius NO, Nilsson TK, Kapaki E, Vassilopoulos D, Waldemar G (2007) A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord 24, 434-440. (Pubitemid 350175903)
36. Xu G, Zhang H, Zhang S, FanX, LiuX(2008) Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int J Clin Pract 62, 1070-1075. (Pubitemid 351793581)
37. Mancinella A, Mancinella M, Carpinteri G, Bellomo A, Fossati C, Gianturco V, Iori A, Ettorre E, Troisi G, Marigliano V (2009) Is there a relationship between high C-reactive protein (CRP) levels and dementia? Arch Gerontol Geriatr 49(Suppl 1), 185-194.
38. O'Bryant SE, Waring SC, Hobson V, Hall JR, Moore CB, Bottiglieri T, Massman P, Diaz-Arrastia R (2010) Decreased C-reactive protein levels in Alzheimer disease. Geriatr Psychiatry Neurol 23, 49-53.
39. Lo RY, Hubbard AE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS, Weiner MW, Jagust WJ, Alzheimer's Disease Neuroimaging, Initiative (2011) Longitudinal change of biomarkers in cognitive decline. Arch Neurol 68, 1257-1266.
40. Cullum CM, Saine K, Chan LD, Martin-Cook K, Gray KF, Weiner MF (2001) Performance-Based instrument to assess functional capacity in dementia: The Texas functional living scale. Neuropsychiatry Neuropsychol Behav Neurol 14, 103-108. (Pubitemid 32549934)